Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Hall

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|August 1, 2018
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?Mareike K Thompson, Philip Poortmans, Anthony J Chalmers, et al.
Frontiers in Oncology|April 20, 2017
R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation OncologyHelena M Verkooijen, Linda G W Kerkmeijer, Clifton D Fuller, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
BMC Medical Research Methodology|July 27, 2020
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practiceAgnieszka Lemanska, Rachel C Byford, Clare Cruickshank, et al.
European Urology|October 23, 2025
Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B StudyRagu Ratnakumaran, Douglas H Brand, Archana Sasitharan, et al.
European Urology|December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 TrialSyed A Hussain, Nuria Porta, Emma Hall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2012
Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trialSarah L Gulliford, Aisha B Miah, Sinead Brennan, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B StudyRagu Ratnakumaran, Archana Sasitharan, Asadullah Khan, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|August 1, 2018
Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?Mareike K Thompson, Philip Poortmans, Anthony J Chalmers, et al.
Frontiers in Oncology|April 20, 2017
R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation OncologyHelena M Verkooijen, Linda G W Kerkmeijer, Clifton D Fuller, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate CancerAnna C Wilkins, Barry Gusterson, Zsolt Szijgyarto, et al.
BMC Medical Research Methodology|July 27, 2020
Linkage of the CHHiP randomised controlled trial with primary care data: a study investigating ways of supplementing cancer trials and improving evidence-based practiceAgnieszka Lemanska, Rachel C Byford, Clare Cruickshank, et al.
European Urology|October 23, 2025
Exploring Factors Associated with Late Urinary Toxicity After Prostate Stereotactic Body Radiotherapy: Findings from the PACE-B StudyRagu Ratnakumaran, Douglas H Brand, Archana Sasitharan, et al.
European Urology|December 9, 2020
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 TrialSyed A Hussain, Nuria Porta, Emma Hall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2012
Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trialSarah L Gulliford, Aisha B Miah, Sinead Brennan, et al.
Technical Innovations & Patient Support in Radiation Oncology|March 21, 2024
"Why am I still suffering?": Experience of long-term fatigue and neurocognitive changes in oropharyngeal cancer survivors following (chemo)radiotherapyZsuzsanna Iyizoba-Ebozue, Emma Nicklin, James Price, et al.
Clinical and Translational Radiation Oncology|September 30, 2020
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)Isabel Syndikus, Clare Cruickshank, John Staffurth, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B StudyRagu Ratnakumaran, Archana Sasitharan, Asadullah Khan, et al.
Pageof 23